International Business: Novo Nordisk-owner to expand in India this year gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.
Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, plans to open an office in India this year to tap innovation and a growing healthcare market, its CEO Kasim Kutay said on Tuesday. The firm, whose assets under management rose to 149 billion euros ($163 billion) at the end of 2023 from 108 billion a year earlier, manages a portfolio of 170 companies across life sciences and capital investments in equities, fixed-income assets, and real estate. It has seen a surge in revenue from Novo Nordisk, the maker of blockbuster obesity drug Wegovy and diabetes treatment Ozempic.
By Jacob Gronholt-Pedersen COPENHAGEN (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, plans to open an office in India this year to tap innovation and a growing healthcare market, its CEO Kasim Kutay.
uniQure (NASDAQ:QURE – Get Free Report) COO Pierre Caloz sold 9,455 shares of the business’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $6.47, for a total transaction of $61,173.85. Following the transaction, the chief operating officer now directly owns 85,643 shares of the company’s stock, […]
uniQure Inc.: uniQure Announces 2023 Financial Results and Highlights Recent Company Progress finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.